Organization

BioMarin

Biotechnology company reporting long-term Pompe disease treatment results.

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Biotechnology company reporting long-term Pompe disease treatment results. Reported in the October 3 newsletter; not independently verified.

Development timeline

Newest reporting dates first. Reporting dates may differ from event dates.

    Knowledge graphopen in browser →

    Cite or correct this record

    Suggest a correction — opens a GitHub draft for you to review and submit.